| Primary |
| Hypertonic Bladder |
25.0% |
| Pollakiuria |
14.3% |
| Urge Incontinence |
10.7% |
| Urinary Incontinence |
10.7% |
| Hypertension |
7.1% |
| Arthritis |
3.6% |
| Bladder Disorder |
3.6% |
| Constipation |
3.6% |
| Dysuria |
3.6% |
| Essential Hypertension |
3.6% |
| Incontinence |
3.6% |
| Micturition Urgency |
3.6% |
| Nocturia |
3.6% |
| Renal Failure Chronic |
3.6% |
|
| Ocular Hypertension |
12.0% |
| Dyspnoea |
8.0% |
| Septic Shock |
8.0% |
| Transitional Cell Carcinoma |
8.0% |
| Abnormal Dreams |
4.0% |
| Anaphylactic Reaction |
4.0% |
| Apathy |
4.0% |
| Bladder Cancer |
4.0% |
| Constipation |
4.0% |
| Dry Mouth |
4.0% |
| Dysuria |
4.0% |
| Epilepsy |
4.0% |
| Erythema |
4.0% |
| Fatigue |
4.0% |
| Gastric Haemorrhage |
4.0% |
| Productive Cough |
4.0% |
| Psychiatric Symptom |
4.0% |
| Pyrexia |
4.0% |
| Rash |
4.0% |
| Shock |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
73.9% |
| Parkinson's Disease |
8.7% |
| Benign Prostatic Hyperplasia |
5.2% |
| Hypertonic Bladder |
1.7% |
| Meniere's Disease |
1.7% |
| Pollakiuria |
1.7% |
| Schizophrenia |
1.7% |
| Cerebrovascular Accident |
0.9% |
| Convulsion |
0.9% |
| Herpes Zoster Ophthalmic |
0.9% |
| Incontinence |
0.9% |
| Nocturia |
0.9% |
| Urinary Incontinence |
0.9% |
|
| Death |
13.0% |
| Benign Prostatic Hyperplasia |
8.7% |
| Cardiac Arrest |
8.7% |
| Coronary Artery Disease |
8.7% |
| Intentional Drug Misuse |
8.7% |
| Respiratory Arrest |
8.7% |
| Toxicity To Various Agents |
8.7% |
| Transient Ischaemic Attack |
8.7% |
| Constipation |
4.3% |
| Hepatitis |
4.3% |
| Neurotoxicity |
4.3% |
| Pyrexia |
4.3% |
| Sudden Death |
4.3% |
| Urinary Incontinence |
4.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.2% |
| Adverse Event |
11.9% |
| Prophylaxis |
11.5% |
| Drug Use For Unknown Indication |
6.9% |
| Rheumatoid Arthritis |
6.0% |
| Hypertension |
5.6% |
| Muscle Spasms |
3.7% |
| Cardiac Disorder |
2.8% |
| Urinary Tract Infection |
2.7% |
| Obesity |
2.2% |
| Diabetes Mellitus |
2.1% |
| B-cell Lymphoma |
1.8% |
| Bladder Disorder |
1.6% |
| Hypertonic Bladder |
1.5% |
| Schizophrenia |
1.5% |
| Arthralgia |
1.4% |
| Angina Pectoris |
1.3% |
| Diffuse Large B-cell Lymphoma |
1.2% |
| Parkinson's Disease |
1.2% |
| Depression |
1.1% |
|
| Weight Increased |
17.1% |
| Shock |
8.5% |
| Weight Decreased |
6.8% |
| Urinary Tract Infection |
6.0% |
| Pancreatitis Acute |
5.1% |
| Pollakiuria |
5.1% |
| Vasculitic Rash |
5.1% |
| Erythema Multiforme |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Malaise |
4.3% |
| Tardive Dyskinesia |
4.3% |
| Vomiting |
4.3% |
| Headache |
3.4% |
| Loss Of Consciousness |
3.4% |
| Pneumonia |
3.4% |
| Swelling Face |
3.4% |
| Visual Impairment |
3.4% |
| Balance Disorder |
2.6% |
| Fall |
2.6% |
| General Physical Health Deterioration |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
|
